UBS AM
LOXO

UBS AM’s Loxo Oncology, Inc LOXO Stock Holding History

UBS AM’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-161,515
Closed -$22.6M – 2843
2018
Q4 		$22.6M Sell
161,515
-647
-0.4% -$98.2K 0.02% 680
2018
Q3 		$27.7M Sell
162,162
-20,352
-11% -$3.42M 0.02% 669
2018
Q2 		$31.7M Sell
182,514
-16,694
-8% -$2.51M 0.02% 652
2018
Q1 		$23M Sell
199,208
-12,026
-6% -$1.28M 0.02% 732
2017
Q4 		$17.8M Buy
211,234
+4,193
+2% +$350K 0.02% 779
2017
Q3 		$19.1M Sell
207,041
-33,297
-14% -$2.59M 0.02% 737
2017
Q2 		$19.3M Buy
240,338
+63,678
+36% +$3.53M 0.02% 752
2017
Q1 		$7.43M Sell
176,660
-39,296
-18% -$1.62M 0.01% 952
2016
Q4 		$6.94M Sell
215,956
-14,619
-6% -$375K 0.01% 931
2016
Q3 		$6.04M Buy
230,575
+21,477
+10% +$562K 0.01% 986
2016
Q2 		$4.85M Buy
209,098
+128,754
+160% +$3.21M 0.01% 1021
2016
Q1 		$2.2M Buy
+80,344
New +$1.68M ﹤0.01% 1328

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

UBS AM's LOXO Position: Q1 2019 in Review

UBS AM sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 161,515 shares — an estimated $22.6M sold.

UBS AM first reported a position in LOXO in Q1 2016 and held it in 12 quarters. The position peaked at $31.7M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • UBS AM reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • UBS AM sold 161,515 Loxo Oncology, Inc shares in Q1 2019, an estimated $22.6M.
  • UBS AM first reported a position in Loxo Oncology, Inc in Q1 2016 and held it in 12 quarters.
  • UBS AM's Loxo Oncology, Inc position peaked at $31.7M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on UBS AM's 13F filing for Q1 2019, filed 14 May 2019.